Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro Authors: Maja Petrović, Simona Lapčević, Ivana Z Matić, Luka Bojić, Marina Nikitović, Tatjana Stanojković, Danijela Stanisavljević Ninković Published: 2026 ABSTRACT AbstractGlioblastoma (GBM) is the most common and aggressive primary brain tumor in adults. Despite current standard therapies, including surgery, radiotherapy, and temozolomide treatment, median survival remains less than 15 months, underscoring the urgent need for novel therapeutic strategies, with microRNAs representing a promising approach. Although the tumor-suppressive role of miR-219 in glioma has been reported, its molecular mechanisms and therapeutic potential remain incompletely understood, especially in the context in combination with standard-of-care treatments. Therefore, the aim of this study was to specifically focused on evaluating miR-219 effects on GBM in vitro, in combination with radiation and temozolomide. Our study indicates that miR-219 may modulate tumor-related processes through the negative regulation of target genes such as REST and AKAP13, while its overexpression appears to reinforce the effects of irradiation and TMZ by reducing malignant properties in GBM cells, in both 2D and 3D, and in increasing apoptotic susceptibility in GBM spheroids. Collectively, these findings support further investigation of miR-219 in the context of GBM therapy and suggest that it may contribute to improved treatment responses and reduced treatment resistance.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-56920-9.Keywords: Glioblastoma, miR-219, Radiosensitivity, Temozolomide, Irradiation, Tumor suppressorSubject terms: Cancer, Oncology Introduction Glioblastoma (GBM) is the most common and aggressive type of brain cancer found in adults. It is known for its fast growth and highly invasive nature, which typically results in a poor outlook for patients, even with intensive therapy efforts1. According to the fifth edition of the WHO Classification of Central Nervous System (CNS) tumors, GBM is classified as an 'adult-type diffuse glioma’2. The standard therapy for GBM includes surgical resection followed by radiotherapy combined with daily temozolomide (TMZ) treatment. Radiotherapy is used to eliminate remaining cancer cells, while TMZ, an oral alkylating chemotherapy drug, enhances the cytotoxic effects of radiation and has been associated with improved overall survival3. Despite comprehensive treatment, GBM remains highly aggressive, with recurrence in 75–90% of cases typically near the original tumor site and multiple lesions occurring in about 5% of patients1. In addition, the median survival for patients treated with a combination of radiotherapy and TMZ is only 14.6 months, with a 5-year overall survival rate of 9.8%1. As its aggressiveness is primarily driven by pronounced resistance to both radiotherapy and chemotherapy, highly invasive nature and significant cellular and molecular heterogeneity, the treatment of GBM remains one of the greatest challenges in clinical oncology. MicroRNAs (miRNAs) are small, endogenously expressed RNA molecules, typically 19–25 nucleotides long, that do not encode proteins but act as post-transcriptional regulators of gene expression4. Approximately 30% of human genes are regulated by miRNAs. Their mechanism of action involves the silencing of messenger RNAs (mRNAs) through a process known as RNA interference (RNAi), which can result in mRNA degradation or sequence-specific inhibition of mRNA translation3. miRNAs are evolutionarily conserved and play key roles in various cellular processes including cell proliferation, migration, invasion, apoptosis, cell cycle, and the maintenance of stem cell–like properties, as well as sensitivity and resistance to therapy4,5. During tumor development, miRNAs can function as oncogenes (oncomiRs) or tumor suppressors3. Consequently, they represent promising targets for development of novel and more effective therapeutic strategies for treatment of GBM. The brain-specific miRNA, miR-219, is recognized as a tumor suppressor in human cancers, including glioma6–10. Literature data revealed that overexpression of this miRNA in glioma cell lines suppresses cell proliferation, anchorage-independent growth, and migration by repressing Epidermal Growth Factor Receptor (EGFR) translation through direct binding to its 3′-UTR9. Also, ectopic expression of miR-219 inhibited proliferation and invasion, and induced apoptosis of GBM cells in vitro and in vivo by targeting Roundabout Guidance Receptor 1 (ROBO1)6. Additionally, miR-219 suppresses proliferation, migration, and invasion of U87 GBM cells by directly targeting gene for SALL4, a gene upregulated in glioma and associated with higher tumor grade. These results suggested that the miR-219/SALL4 axis plays a tumor-suppressive role and may have clinical relevance in glioma progression7. Based on the current evidence, miR-219 represents a promising therapeutic candidate in GBM. However, the comprehensive role of miR-219 in GBM biology as well as its potential to modulate radiation and TMZ sensitivity in GBM cells has not yet been fully elucidated. In this study, we comprehensively investigated the role of miR-219 in GBM biology using integrated in vitro 2D and 3D models, combined with in silico and molecular analyses, with a focus on miR-219 potential to modulate the treatment response of GBM cells. Beyond confirming its downregulation in GBM, functional analyses indicate that miR-219 may contribute to tumor-related processes through the negative regulation of target genes such as REST and AKAP13. Importantly, this study provides novel evidence of potential linking miR-219 to EMT-related phenotypes in GBM. Furthermore, we show, for the first time, that miR-219 modulates GBM spheroid growth and apoptosis, as well as their treatment response. Notably, our results further show that irradiation and TMZ treatment increased miR-219 expression. Moreover, miR-219 overexpression modulated the response of GBM cells to standard therapies by enhancing the effects of irradiation and, to a lesser extent, TMZ, particularly through the reduction of clonogenic capacity, migration and spheroid characteristics. These findings are extending previous knowledge of miR-219 by directly comparing its efficacy to standard GBM therapy. Results miR-219 expression and identification of its potential target genes in GBM To determine the biological functions of mir-219 in GBM, we first analyze its expression in two GBM cell lines, LN229 and U87, and compared it to that in astrocytes (NT2 A). Analysis showed a significant downregulation of miR-219 in both GBM cell lines, LN229 and U87, with reduction of 99% and 95% compared to astrocytes, respectively (Fig. 1a). Furthermore, this observation was supported by analysis of dataset GSE90604, which revealed that miR-219 expression is reduced by 41% in GBM samples compared to healthy brain tissues (controls) (Fig. 1b). In addition, in silico analysis using the TargetScan, miRDB and miRWalk online databases was used to identify potential target genes of miR-219. By intersecting the results from these databases (Fig. 1c), we identified 49 potential target genes of miR-219 (Fig. S1). Functional enrichment analyses of these 49 target genes revealed their involvement in brain development-related biological processes, including nervous system development, as well as negative regulation of neural differentiation and negative regulation of stem cell differentiation (Fig. 1d). Our analysis revealed genes that are upregulated in the miR-219 cluster, including PKNOX1, DAZAP1, BTBD7, REST, CECR2, ANKRD52, ELMOD2, ATG14, AKAP13 and DCP2 (Fig. 1e). Additionally, spearman correlation analysis demonstrated significant inverse associations between miR-219 expression and all four candidate target genes (indicated with colored boxes at Fig. 1e). ANKRD52 showed the strongest negative correlation (ρ = − 0.31, FDR = 2.4 × 10−5), followed by AKAP13 (ρ = − 0.25, FDR = 4.8 × 10−4). DAZAP1 (ρ = − 0.24, FDR = 5.8 × 10−4) and REST (ρ = − 0.24, FDR = 5.8 × 10−4) also exhibited significant inverse correlations with miR-219 (Fig. S2). These results indicate that higher miR-219 expression is consistently associated with reduced expression of these genes in glioblastoma, supporting a potential repressive regulatory relationship. To further validate the predicted miR-219 target genes, LN229 and U87 cells were transduced with either an empty vector (pGP) or miR-219 overexpression vector (miR-219). Fluorescence microscopy confirmed the GFP expression in transduced LN229 (Fig. S3a) and U87 (Fig. S3b) cells. Overexpression of miR-219 was also confirmed by RT-qPCR in transduced LN229 (Fig. S3c) and U87 (Figure S3d) cells compared with pGP controls. RT-qPCR analysis revealed that overexpression of miR-219 led to a significant downregulation of REST in both LN229 and U87 cells by 45% and 44.6% respectively (Fig. 1f) and AKAP13 in LN229 cells by 23.2% (Fig. 1g) compared to control cells. These results support the predicted regulatory relationship and suggest that miR-219 may directly or indirectly repress the expression of these genes in GBM cells. Collectively, these findings indicate that miR-219 is markedly downregulated in GBM and may contribute to tumor-related processes through the negative regulation of target genes such as REST and AKAP13. Expression of miR-219 and identification of its potential target genes in GBM. (a) Expression of miR-219 in GBM cell lines (LN229 and U87) and astrocytes (NT2 A) Statistical significance was determined using Student’s t-test: **** p ≤ 0.0001. (b) Comparison of miR-219 expression levels between GBM tissue samples and healthy brain tissues based on dataset GSE90604. Statistical significance was determined using Student’s t-test, p = 0.0141. (c) Venn diagram of predicted miR-219 target genes shared across TargetScan, MirDB and miRWalk. (d) Bar plot showing enriched biological processes among miR-219 target genes. (e) Predicted downstream target genes of miR-219 with color intensity representing the log fold change in expression of these genes in GBM. Spearman correlation analysis demonstrated significant inverse associations between miR-219 expression and all four candidate target genes (indicated with colored boxes). (f) qRT-PCR analysis of REST gene expression after trunsduction with empty vector (pGP) and vector expressing miR-219. GAPDH was used as the loading control. Data are presented as the means ± SD of three independent transfection experiments. Mean values were compared with Student’s t-test and p-values calculated *p ≤ 0.05, **p ≤ 0.01. g) qRT-PCR analysis of AKAP13 gene expression after trunsduction with empty vector (pGP) and vector expressing miR-219. GAPDH was used as the loading control. Data are presented as the means ± SD of three independent transfection experiments. Mean values were compared with Student’s t-test and p-values calculated, **p ≤ 0.01. miR-219 expression upon TMZ and radiation treatment in GBM Given that standard GBM therapy includes surgical resection followed by radiation and TMZ treatment11, we investigated whether these treatments modulate miR-219 expression in LN229 and U87 cells. Firstly, the impact of 4 Gy radiation and 50 µM TMZ on LN229 and U87 cell survival 48 h post-treatment using clonogenic assay was analyzed (Fig. 2 a, b, d, e). Both treatments significantly reduced the clonogenic potential of the two GBM cell lines (Fig. 2a, b, d, e). Irradiation with 4 Gy induced a significant increase in miR-219 expression 48 h post-treatment, to approximately 215% in LN229 cells (Fig. 2c) and 275% in U87 cells (Fig. 2f) relative to control levels (set at 100%). Treatment with 50 µM TMZ also significantly increased miR-219 expression to approximately 157% in U87 cells (Fig. 2f), while 50 µM TMZ showed no effect on the expression of miR-219 in LN229 cells (Fig. 2c), relative to control levels (100%). These findings suggest a potential role of miR-219 in the response of GBM cells to standard therapy. miR-219 expression in GBM cells following TMZ and radiation treatment. (a, b) Effect of 4 Gy irradiation and 50 µM TMZ on the number of colonies formed by LN229 cells. (c) Expression of miR-219 in LN229 cells 48 h post 4 Gy irradiation and 50 µM TMZ treatment, compared with control (untreated) cells designed as C. (d, e) Effect of 4 Gy irradiation and 50 µM TMZ on the number of colonies formed by U87 cells. (f) Expression of miR-219 in U87 cells 48 h post 4 Gy irradiation or 50 µM TMZ treatment, compared with control (untreated) cells designed as C. Data are presented as mean ± SD from three independent biological experiments (each performed in technical triplicates). Statistical significance was determined using Student’s t-test: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. Effects of miR-219 overexpression, alone and in combination with irradiation and TMZ, on GBM cell survival Next, we explored the impact of miR-219 overexpression, alone or in combination with irradiation and TMZ on the viability of LN229 and U87 cells. These results indicated that miR-219 overexpression alone decreased the viability of LN229 cells only by approximately 14% (Fig. 3a) (q = 0.000768). A similar effect was observed following irradiation (4 Gy), with a reduction of 13.63% (q = 0.018215) and in combined treatment by 19.15% (q = 0.022085) compared with pGP control cells under the same conditions (Fig. 3a). In U87 GBM cells, miR-219 overexpression did not result in statistically significant changes in cell viability under any of the tested conditions, including both irradiation (4 Gy) and TMZ, or combined treatment. Although a minor reduction in viability was observed across all conditions (ranging from 4.99 to 6.71%), these differences were not statistically significant after FDR correction (all q > 0.13). The most pronounced but still non-significant decrease was observed following TMZ treatment (6.71% reduction; q = 0.134) (Fig. 3b). Effects of miR-219 overexpression alone and in combination with irradiation and TMZ on GBM cell survival. (a, b) The effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on viability of LN229 (a) and U87 (b) cells, assessed by MTT assay. Viability of cells transduced with the pGP vector and receiving no treatment (irradiation or TMZ) was set to 100%. Data are presented as mean ± SD from three independent biological experiments (each performed in technical triplicates). Statistical significance was determined using multiple t-tests with false discovery rate (FDR) correction (1%). Adjusted p-values (q-values) were used to account for multiple comparisons. Statistical significance is indicated as: *q ≤ 0.05, **q ≤ 0.01, ***q ≤ 0.001. (c, d) The effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on colony formation ability of LN229 (c) and U87 cells (d). Images are representative of three independent experiments. These findings suggest that effect of miR-219 overexpression on cell viability, either alone or in combination with irradiation and TMZ, exerts no detectable effect on U87 cell viability, while inducing a modest reduction in LN229 cell viability alone or in combination with irradiation and irradiation and TMZ. We next examined the effects of miR-219 overexpression, alone or in combination with radiation and TMZ, on the colony forming ability of LN229 and U87 cells. Significant reduction in colony number was observed in miR-219-overexpressing cells compared to pGP control cells in both cell line (Fig. 3c, d). Furthermore, the combination of miR-219 overexpression with either irradiation or TMZ led to an additional decrease in colony formation in both cell lines (Fig. 3c, d). Collectively, these results suggest that miR-219 overexpression has a modest impact on GBM cell viability, while exerting a more pronounced effect on clonogenic capacity and treatment response to irradiation and TMZ. Effect of miR-219 alone and in combination with irradiation and TMZ on the distribution of GBM cells in cell cycle phases We next examined weather miR-219 overexpression, alone or in combination with irradiation and TMZ, affect the distribution of LN229 and U87 cells in cell cycle phases. No significant differences were found in the percentage of cells within G1, S, and G2/M phases following transduction with the miR-219 overexpression vector in either LN229 or U87 cells (Fig. 4). In addition, miR-219 overexpression did not significantly alter cell cycle distribution when combined with irradiation (4 Gy) or TMZ (50 µM) at 48 h post-treatment (Fig. 4). These findings suggest that miR-219 overexpression does not induce cell cycle arrest in LN229 or U87 cells alone or in combination with irradiation and TMZ. Effects of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the distribution of cell cycle phases in GBM cells. (a) Flow cytometry-based assessment of cell cycle phase distribution in LN229 cells transduced with either pGP or miR-219 overexpression vector, 48 h after irradiation or TMZ exposure. (b) Flow cytometry-based assessment of cell cycle phase distribution in U87 cells transduced with either pGP or miR-219 overexpression vector, 48 h after irradiation or TMZ exposure. The proportions of cells in the SubG1, G1, S, and G2/M cell cycle phases from three independent experiments. Data are presented as mean ± SD from three independent biological experiments. Effects of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the migratory capacity of GBM cells The effects of miR-219 overexpression, alone or in combination with irradiation and TMZ, on the migration potential of LN229 GBM cells were assed using in vitro scratch assay. miR-219 overexpression significantly reduced the migration of LN229 cells by 28% (q = 0.002231) (Fig. 5), and further enhanced the inhibitory effect of irradiation, resulting in reduction of migration by approximately 32% (q = 0.000647) (Fig. 5). In contrast, no additional effect was observed when miR-219 overexpression was combined with TMZ (Fig. 5). These findings demonstrate that miR-219 overexpression suppresses LN229 cell migration and potentiates the anti-migratory effect of irradiation. Effects of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the migratory capacity of LN229 cells. (a) The effect of miR-219 overexpression, alone or in combination with irradiation and TMZ, on migration capacity of LN229 cells was observed by in vitro scratch assay. Representative images of cell migration captured before treatment (0 h; left panels) and 24 h post-treatment (24 h; right panels) at 4 × magnification. (b) Migration distances were quantified 24 h post-scratch and expressed relative to the initial gap width of pGP untreated control cells, which was set as 100%. Data are presented as mean ± SD from three independent biological experiments (each performed in technical triplicates). Statistical significance was determined using multiple t-tests with false discovery rate (FDR) correction (1%). Adjusted p-values (q-values) were used to account for multiple comparisons. Statistical significance is indicate as: **q ≤ 0.01, ***q ≤ 0.001. Effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on epithelial–mesenchymal transition –related features in GBM cells To examine the effect of miR-219 overexpression on epithelial–mesenchymal transition (EMT)-related features in GBM cells, we performed single-sample gene set enrichment analysis (ssGSEA) using the Hallmark EMT gene set to assess EMT-associated transcriptional programs more broadly. Correlation analysis revealed a significant inverse association between miR-219 expression and EMT pathway activity (Spearman ρ = − 0.36, p = 1.31 × 10−7), indicating that higher miR-219 expression is associated with lower mesenchymal transition scores across GBM samples (Fig. 6a). Table of genes included in the gene set associated with EMT ranked by the correlation with miR-219 is presented at Fig. S4. To complement these findings, VIMENTIN expression was analysed by immunocitochemistry. Obtained results revealed that miR-219 overexpression significantly reduced VIMENTIN expression in LN229 cells (Fig. 6b). In addition, these decrease was also observed when LN229 cells with miR-219 overexpression were treated with irradiation or TMZ (Fig. 6b). Together, these results suggest that miR-219 is associated with reduced EMT–related features in GBM, and this effect appears to be retained in the presence of irradiation or TMZ treatment. Effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the VIMENTIN expression of GBM cells. (a) The association between miR-219 expression and EMT pathway activity assessed using Spearman correlation; statistical significance was determined using cor.test. (b) The effect of miR-219 overexpression, alone or in combination with irradiation and TMZ, on VIMENTIN protein expression in LN229 cells was assesed by immunocytochemistry. Cell nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. Effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the GBM spheroids To analyse the effect of miR-219 overexpression on GBM spheroid growth, we cultured LN229 and U87, transduced with pGP control vector or miR-219 overexpression vector, as spheroids. Spheroids were treated as described in the Treatment Procedure section and imaged before treatment and four days post-treatment. miR-219 overexpression significantly reduced the growth of untreated LN229 spheroids by 45% (q = 0.002753) compared to pGP control (Fig. 7a). A significant reduction in spheroid growth was also observed following irradiation (27% decrease; q = 0.0246) and TMZ treatment (34.5% decrease; q = 0.0246). Similarly, combined irradiation and TMZ treatment resulted in a 34% reduction in spheroid growth in miR-219 overexpressing cells (q = 0.0028) (Fig. 7a). In U87 spheroids, miR-219 overexpression resulted in a moderate but statistically significant reduction in spheroid growth under several experimental conditions. Under control conditions, miR-219 overexpression reduced spheroid growth by 15% compared to pGP control (q = 0.045) and potentiated the effects of irradiation and combined treatment by 23% (q = 0.045000) and 11% (q = 0.049863), respectively (Fig. 7b). In contrast, TMZ treatment alone did not significantly affect spheroid growth in miR-219 overexpressing cells. Effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the GBM spheroid growth. (a) The effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on LN229 spheroid size. (b) The effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on U87 spheroid size. The size of spheroids from pGP-transduced, untreated cells (no irradiation or TMZ) was set as 100%. Data are presented as mean ± SD from three independent biological experiments (each performed in technical triplicates). Statistical significance was determined using multiple t-tests with false discovery rate (FDR) correction (1%). Adjusted p-values (q-values) were used to account for multiple comparisons. Statistical significance is indicated as: *q ≤ 0.05, **q ≤ 0.01, ***q ≤ 0.001. (c) PI staining of dead cells in 3D spheroids of LN229 and U87 cells. (d) The effect of miR-219 overexpression, alone or in combination with irradiation and TMZ, on Cleaved Caspase 3 (purple) and Cleaved PARP (yellow) protein expression in LN229 spheroids detected by immunocytochemistry. Cell nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. Furthermore, PI staining revealed a higher proportion of dead cells in both LN229 and U87 spheroids overexpressing miR-219 (Fig. 7c). An increase in PI-positive cells was also observed in LN229 miR-219 spheroids treated with irradiation and/or TMZ, whereas in U87 spheroids this effect was noted only with irradiation (Fig. 7c). To further characterize the type of cell death induced by miR-219 overexpression, we performed immunofluorescence analysis of apoptosis markers in LN229 spheroids. An increased expression of Cleaved Caspase-3 and Cleaved PARP was observed in miR-219-overexpressing spheroids, with the most pronounced effect detected upon combined treatment with irradiation and TMZ (Fig. 7d). These findings are consistent with the PI staining results, indicating that miR-219 enhances apoptosis in LN229 spheroids, particularly in combination with standard therapies. The effect of miR-219 on GBM spheroids was further investigated by immunofluorescence analysis of VIMENTIN expression. miR-219 overexpression markedly reduced VIMENTIN expression in LN229 spheroids, particularly without any additional treatment, with a less pronounced effect observed in U87 spheroids (Fig. 8). Effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on the VIMENTIN expression in GBM spheroids. (a) The effect of miR-219 overexpression, alone or in combination with irradiation and TMZ, on VIMENTIN protein expression in LN229 spheroids detected by immunocytochemistry. (b) The effect of miR-219 overexpression, alone and in combination with irradiation and TMZ, on VIMENTIN protein expression in U87 spheroids detected by immunocytochemistry. Cell nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. Overall, these findings indicate that miR-219 overexpression impairs growth and viability of GBM spheroids and promotes apoptosis, with effects that are partially retained and context-dependent under irradiation and TMZ treatment conditions. Discussion Despite standard treatment, which includes surgery followed by irradiation and TMZ treatment, GBM still has a high recurrence rate, because of its heterogeneity, aggressiveness and resistance to existing treatments1. This highlights the urgent need for innovative treatment strategies to improve survival in GBM patients, with miRNAs emerging as one potential therapeutic approach. miR-219 is a brain specific miRNA12 associated with CNS disorders and tumors, including multiple sclerosis, spinal cord injury, Alzheimer’s disease, schizophrenia, Parkinson disease13 glioma6,9 and medulloblastoma14. An additional compelling feature of miR-219 is its potential as a therapeutic in diseases like multiple sclerosis and colorectal cancer7,15. Although it has been reported that miR-219 can act as a tumor suppressor in GBM, so far little is known about its potential role in treatment of one of the most aggressive brain tumors. We demonstrated that miR-219 expression is significantly decreased in LN229 and U87 GBM cell lines compared to normal astrocytes, as well as in GBM tissue samples compared to normal brain tissue. These findings are in accordance with previous studies showing downregulation of miR-219 expression in GBM6,9,10. However, beyond confirming its downregulation, our study provides additional insight into the potential regulatory landscape associated with miR-219 in GBM. The functional enrichment analyses of miR-219 target genes revealed their involvement in brain development-related biological processes, including system and nervous system development, as well as negative regulation of stem cell, neuronal and mesenchymal stem cell differentiation. To better understand the regulatory pathways of miR-219, we performed an in silico analysis and identified target genes that are upregulated in the miR-219 cluster. Studies showed that all of these genes are overexpressed in GBM compared to normal brain tissue16–20 suggesting that they act as oncogenes in this tumor. These findings implied that miR-219 overexpression in GBM cell lines may modulate some of these oncogenes directly or indirectly. Additionally, the low miR-219 expression observed in GBM, which is in correlation with the high expression of over mentioned oncogenes, further supports a tumor suppressor role of miR-219 in this tumor. A systematic correlation analysis in the TCGA GBM cohort revealed significant inverse correlations between miR-219 and multiple predicted targets, including ANKRD52, AKAP13, DAZAP1, and REST, while RT-qPCR analysis revealed that overexpression of miR-219 led to a significant downregulation of REST and AKAP13 in both GBM cell lines. Both REST and AKAP13 are associated with poor prognosis in glioma patients and functionally, the suppression of REST and AKAP13 may contribute to reduced proliferative capacity, impaired migration, and partial reprogramming of GBM cells toward a less aggressive phenotype16,21, suggesting a potential role of miR-219 in modulating key regulators of GBM progression. Although the predicted targets were validated at the mRNA level by RT-qPCR, a key limitation of this study is the lack of functional validation of direct miR-219–target interactions. Future studies should address this by employing luciferase reporter assays and protein-level analyses following miR-219 perturbation. During cancer progression, EMT is associated with increased invasive capacity, enhanced cellular plasticity, and the acquisition of stem-like properties22. In this context, our findings suggest that miR-219 may contribute to the modulation of EMT-related features in GBM, as indicated by reduced EMT transcriptional program activity and decreased VIMENTIN expression following miR-219 overexpression in 2D and 3D cells. Importantly, VIMENTIN represents a key intermediate filament protein involved in the acquisition of a mesenchymal, invasive phenotype23. In addition, EMT-related gene set analysis identified several genes whose expression inversely correlated with miR-219 levels, including core components of EMT-associated transcriptional programs such as LAM2, VIMENTIN, MMP2, and CADH2. Overall, these results provide novel evidence that miR-219 is linked to EMT-associated phenotypes in GBM, but further in vivo studies and functional validation of direct EMT-related targets are required to confirm and extend these findings. Previous studies have shown that miR-219 acts as a tumour suppressor in GBM cell lines by inhibiting cell proliferation, colony formation, and migration6,9. Consistent with these findings, our study also showed that overexpression of miR-219 significantly reduced viability, colony formation ability, and migration of LN229, and also decreased colony formation of U87 cells. Interestingly, miR-219 overexpression had no detectable effect on cell cycle phase distribution in GBM cells, indicating that its inhibitory effect is cell-cycle independent. Permanent human GBM cell lines cannot fully recapitulate the heterogeneity and complexity of GBM tumors or their complex interactions with the tumor microenvironment. Traditional 2D culture models are particularly limited in simulating in vivo tumor conditions, whereas 3D culture systems can better mimic these aspects and improve the physiological relevance of in vitro experiments24. Therefore, to gain the deeper insight into miR-219 function in GBM cell behaviour, we established 3D spheroid cultures of LN229 and U87 cells transduced with either pGP control vector or miR-219 expression vector. Here, for the first time the impact of miR-219 overexpression on GBM 3D spheroids was investigated. Results showed that this miRNA significantly inhibited growth of both LN229 and U87 spheroids. Particularly, overexpression of miR-219 in LN229 spheroid cultures led to a marked increase in apoptotic markers, including Cleaved PARP and Cleaved Caspase-3, accompanied by enhanced PI uptake, indicating late-stage apoptosis and loss of membrane integrity. These findings suggest that miR-219 may promote apoptotic cell death pathways and compromise spheroid integrity, thereby contributing to reduced cellular survival in a 3D tumor-like context. In addition, reduced spheroid growth was associated with decreased VIMENTIN expression in 3D models, suggesting that miR-219 may also attenuate mesenchymal-like features linked to tumor invasiveness and cellular plasticity. Notably, this study demonstrates for the first time that miR-219 overexpression exerts a strong antitumor effect in GBM 3D spheroid models. miR-219 is recognized as radiosensitizer in non-small cell lung cancer cells25, but there is no literature reporting the possible role of this miRNA in the response of GBM cells to irradiation or TMZ treatment. This prompts us to investigate if irradiation and TMZ affect miR-219 expression in GBM cell lines. Our results showed increased expression of miR-219 following irradiation and TMZ treatments in GBM cells, suggesting that miR-219 may be associated with the cellular response to these therapies. To the best of our knowledge, this is the first report on the effects of irradiation and TMZ on miR-219 expression levels in GBM. To further explore the therapeutic relevance of miR-219, we investigated its effects in combination with standard GBM treatments, irradiation and TMZ. The combination of miR-219 overexpression with either irradiation or TMZ further enhanced the antitumor effects in GBM cells across most of the analyzed processes, although no significant changes in cell cycle distribution were observed. First, miR-219 upregulation potentiated the effects of irradiation and TMZ on the clonogenic capacity of both LN229 and U87 cells. Moreover, miR-219 overexpression reduced the migratory potential of irradiated LN229 cells and was accompanied by decreased VIMENTIN expression in both 2D and 3D models. These findings are particularly relevant, as the strategic integration of miRNA-based therapies with current standard treatments represents a promising direction for future cancer therapy27. It would therefore be valuable to further investigate whether these effects are mediated through the regulation of specific EMT-related genes identified in our analysis, especially in the context of irradiation. In addition, our results suggest that miR-219 may exert stronger effects particularly on LN229 spheroids than standard irradiation and TMZ treatment alone. In LN229 spheroids, miR-219 overexpression enhanced the effects of irradiation, TMZ, and their combined treatment on spheroid growth, whereas in U87 spheroids, miR-219 did not significantly potentiate only the effects of TMZ alone. A similar pattern was observed following PI staining where miR-219 overexpression intensified the effects of irradiation, TMZ, and their combined treatment in LN229 cells, while no significant enhancement only of the TMZ effect was detected in U87 cells. Furthermore, the apoptotic markers Cleaved Caspase-3 and Cleaved PARP showed the most pronounced increase when miR-219 overexpression was combined with irradiation and TMZ treatment. Together, the PI staining results and immunofluorescence analysis of Cleaved Caspase-3 and Cleaved PARP indicate that miR-219 may enhance the apoptotic response induced by standard GBM therapies. Overall, the data provide preliminary evidence that miR-219 have adjunctive potential in standard GBM therapy. Even though in vitro studies of GBM provide a valuable foundation for in vivo and ex vivo research, their translational relevance to humans remains limited26. Mouse models, including orthotopic and genetically modified models, which naturally encompass modeling of the GBM microenvironment restricted only by cross-species variances, have shown to be of great value for preclinical GBM investigations, as well as for the validation of in vitro and ex vivo findings27. In addition, ex vivo organotypic brain slice models maintain key physiological features acting as a bridge between in vitro and in vivo models in GBM research, particularly in tumor microenvironment and therapeutic responses28. Using only in vitro models (2D and 3D cultures) has limited the translational potential of this study. Even though our results showed increased expression of miR-219 following irradiation and TMZ treatments in GBM cells, suggesting that miR-219 may be associated with the cellular response to these therapies, our functional data indicate that miR-219 can modulate only certain aspects of irradiation and TMZ response. To clarify whether miR-219 could serve as a biomarker of treatment response or a potential therapeutic target further studies are needed, including the use of more advanced in vitro systems, such as patient-derived models and organoid-based approaches, as well as in vivo models, which may better recapitulate the complexity and heterogeneity of GBM compared to conventional 2D cell cultures and 3D spheroid models. Therefore, future studies using ex vivo organotypic brain slice models and in vivo GBM mouse models are warranted to validate the effects of miR-219 in a more physiologically relevant context and to assess its potential as a therapeutic modulator in GBM.The differential responses of LN229 and U87 cell lines to miR-219 overexpression observed in this study further highlight the cell line–specific effects and underscore the importance of patient-derived models for the development of personalized therapeutic strategies29. In addition, these GBM cell lines are typically GBM cell lines with different mutation profile, LN229 has mutated TP53 gene, homozygous p16 and p14ARF deletion, and wild-type PTEN gene while the U87 cell has a wild type TP53 gene and a mutated PTEN gene with homozygous p16 and p14ARF deletion26. U87 cells exhibit significantly higher CCNE1 (Cyclin E1) expression compared to LN229, which has been associated with TMZ resistance. In contrast, LN229 cells show reduced BRCA2 levels, a factor linked to increased TMZ sensitivity. These differences in CCNE1 and BRCA2 expression may underlie the distinct responses of U87 and LN229 cells to TMZ treatment and highlight potential targets for improving therapeutic efficacy in GBM26. LN229 cells express multiple stem cell markers (Nestin, Sox2, Musashi-1, CD44), whereas U87 cells lack their expression. Consistently, LN229 exhibits higher migration, colony formation, and sphere-forming capacity compared to U87. Additionally, LN229 sphere cells show greater sensitivity to TMZ, while U87 cells display lower cytotoxic response30. Since LN229 cells expressed genes related to the proneural subtype including NKX2-2, OLIG2, SOX2, and ERBB3, this cell line is classified as proneural, while U87 is classified as mesenchymal subtype31. Collectively, these genetic, phenotypic, and subtype differences likely contribute to the more pronounced response of LN229 cells in certain investigated processes, particularly regarding response to irradiation and TMZ treatment, highlighting the context-dependent nature of miRNA-mediated therapeutic modulation. Our study indicates that miR-219 may modulate tumor-related processes through the negative regulation of target genes such as REST and AKAP13, while its overexpression appears to reinforce the effects of irradiation and TMZ by reducing malignant properties in both 2D and 3D GBM cells, as well as increasing apoptotic susceptibility in GBM spheroids, highlighting miR-219 potential as a promising adjunct to standard GBM therapy. Collectively, these findings support further investigation of miR-219 in the context of GBM therapy and suggest that it may contribute to improved treatment responses and reduced treatment resistance. Methods Cell culture Human GBM cell lines U87 MG U87-MG (ATCC® HTB-14™) and LN229 (ATCC® CRL-2611™), obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Capricorn Scientific, Ebsdorfergrund, Germany) supplemented with 10% fetal bovine serum (FBS) (Capricorn Scientific, Ebsdorfergrund, Germany) and 1% penicillin–streptomycin (Capricorn Scientific, Ebsdorfergrund, Germany). The cells were maintained at 37 °C in a humidified atmosphere with 5% CO2. NT2/D1 derived astrocytes (NT2-A) were obtained according to the published protocols upon differentiation of human pluripotent NT2/D1 embryonal carcinoma cells (ATCC® CRL 1973™) cell line in culture by adding 10 μM all trans retinoic acid (SigmaAldrich, USA) for four weeks32. Data acquisition In our analysis we have utilized the publicly available array dataset GSE90604 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90604) containing coding and non-coding RNA expression information from 16 GBM and 7 healthy tissue samples. This dataset was subjected to an analysis using GEO2R (https://www.ncbi.nlm.nih.gov/geo/geo2r/) tool to identify differentially expressed genes and miRNAs between tumor tissues and healthy controls. Regulation network identification To identify genes regulated by mir-219 we analyzed data from TargetScan (https://www.targetscan.org/vert_80/), miRDB (https://mirdb.org) and miRwalk (http://mirwalk.umm.uni-heidelberg.de) which were queried for the targets of this miRNA. Network construction of the identified genes and Gene Ontology biological process enrichment analysis was carried out using Cytoscape (version 3.10.4, https://cytoscape.org). Targets of the upregulated hsa-miRNA-219a-5p (miR-219) were identified by overlapping the regulatory network with the set of upregulated genes. TCGA GBM preprocessing and correlation analysis mRNA and miRNA expression data for glioblastoma (GBM) were obtained from TCGA (https://www.cancer.gov/ccg/research/genome-sequencing/tcga) using TCGAbiolinks (version 2.34.1, https://bioconductor.org/packages/release/bioc/html/TCGAbiolinks.html). Raw gene-level counts and miRNA read counts were downloaded and processed with GDCprepare. Expression matrices were constructed and harmonized by retaining only samples with matched barcodes across both datasets. Lowly expressed features were filtered out (mean count ≤ 10 for mRNA, ≤ 5 for miRNA). Data were normalized using variance stabilizing transformation implemented in DESeq2 (version 1.46.0, https://bioconductor.org/packages/release/bioc/html/DESeq2.html) following size factor estimation. For miRNA analysis, expression of miR-219a was quantified by averaging normalized counts from both genomic loci (hsa-mir-219a-1 and hsa-mir-219a-2). A predefined set of candidate target genes was subsetted, and Spearman rank correlations between miR-219 expression and each gene were computed across matched samples. Corresponding p-values were obtained via cor.test and adjusted for multiple testing using the Benjamini–Hochberg method. Genes with significant negative correlations (FDR < 0.05) were retained. EMT pathway activity inference and correlation with miR-219 EMT pathway activity was quantified using single-sample gene set enrichment analysis (ssGSEA). The EMT gene set was obtained from the Hallmark collection via msigdbr, and restricted to genes present in the normalized mRNA expression matrix. Enrichment scores were computed per sample using the ssGSEA method implemented in GSVA (version 2.0.7, https://www.bioconductor.org/packages/release/bioc/html/GSVA.html), generating a EMT activity score for each tumor. These scores were then aligned with matched miR-219 expression values across samples. The association between miR-219 expression and EMT pathway activity was assessed using Spearman correlation, and statistical significance was determined using cor.test. Cell irradiation and TMZ treatment To analyze miR-219 expression following irradiation, U87 and LN229 cell lines were exposed to a 4 Gy irradiation using an Elekta Medical linear accelerator (Elekta AB, Stockholm, Sweden), with X-ray radiation generated at 6 MeV. Dose of 4 Gy was administered at room temperature (RT) and control cells were sham irradiated. Irradiated and sham irradiated cells were subsequently incubated at 37 °C and harvested 48 h post-treatment for RNA isolation. For the analysis of miR-219 expression after TMZ treatment, the U87 and LN229 cell lines were treated with 50 µM TMZ (Sigma-Aldrich, SAD). Treated and untreated cells were incubated at 37 °C and harvested after 48 h points for RNA isolation. Each treatment was analyzed in at least three independent biological replicates. Colony formation of LN229 and U87 wild type cell lines LN229 and U87 cells were seeded in triplicates in 6-well plates at a density of 800 cells per well. After 24 h cells were exposed to 4 Gy irradiation or treated with 50 µM TMZ, and then incubated for 10 days. Following incubation, the medium was removed and cells were rinsed with 1xPBS, fixed with 3.7% formaldehyde for 20 min, and stained with 0.5% crystal violet for 30 min at RT. Residual staining solution was removed by washing the cells several times with ddH2O. Plates were allowed to air-dry, and the resulting colonies were imaged using digital camera. For spectrophotometric quantification of crystal violet-stained colonies, 1% acetic acid (ZORKA, Šabac, Serbia) was added to each well to solubilize the dye, followed by incubation on a shaker for 1 h at RT. Subsequently, 100 μL of each extraction was measured at 570 nm using a Multiskan SkyHigh microplate spectrophotometer (Thermo Scientific™, Waltham, MA, USA). All experiments were performed with at least three independent biological replicates and three technical repeats. Lentiviral transduction Lentiviral transduction was performed as described in our previous publication33 using a cell line HEK293 (ATCC® CRL-1573™) derived from human embryonic kidney cells for virus production. Accordingly, to produce mature viral particles, HEK293 cells were transfected with plasmids encoding the essential genes for viral particle assembly, along with a plasmid carrying the transgene. Initially, 1.2 × 10⁶ cells were plated in 10 cm2 Petri dishes, and the next day, transient transfection was carried out using polyethyleneimine MAX (PEI-Max) reagent (pH 7.2) (Polysciences Inc., USA). For creating viruses that either overexpress miR-219 or contain the corresponding empty vector, the following components were utilized: 1.7 μg pCMV-VSVG, 1 μg pRSV-REV, 2.5 μg pMDLg/RRE, and 10 μg of either the lentiviral miR-219 overexpression construct (BioCat GmbH, Heidelberg, Germany) or the empty pGreenPuro vector (pGP; SI505A-1, System Biosciences, USA). Both vectors are tagged with Green Fluorescent Protein (GFP) to enable visualization and tracking. After 6 h of incubation, cells were washed and incubated for an additional 48 h in fresh medium. Following this period, the medium was collected and filtered through 0.2 μm pore size filter to remove cellular debris. A transduction-enhancing agent Polybrene (Sigma-Aldrich, SAD) was added to the filtered supernatant in concentration 8 μg/μl to improve the efficiency of viral entry into cells. The prepared infection mix was added to U87 and LN229 cells previously seeded into 10 cm2 Petri dishes. After 6 h cells were washed with Phosphate-Buffered Saline (PBS) and experiments were initiated 5 days post-trunsduction. GFP signal in transduced cells was detected by fluorescence microscopy (Axiovert 5, Zeiss, GMBH, Germany). For RNA isolation and analysis of miR-219 expression cells were harvested at least 5 days after transduction. Three independent transductions were performed. RNA extraction and RT PCR Total RNA was isolated using TRIzol reagent (Invitrogen, USA) in accordance with the manufacturer’s protocol. For the analysis of miR-219 expression the isolated RNA was reverse transcribed using TaqMan® miRNA Assays (Applied Biosystems, Foster City, CA) specific for miR-219 (Cat. No. 4427975; Assay ID 000522) and the small nuclear RNA RNU44 (Cat. No. 4427975; Assay ID 001,095) as previously described33. Quantitative PCR was performed using TaqMan® Universal PCR Master Mix in a CFX Opus Real-Time PCR System (Bio-Rad, Hercules, CA, USA) as previously described33. miR-219 expression levels were quantified in relative units and normalized to the endogenous control RNU44. For experiments involving TMZ treatment or irradiation, untreated cells were used as the calibrator. For experiments assessing the efficiency of miR-219 lentiviral transduction, cells transduced with a control vector were used as the calibrator. Relative expression of miR-219 was calculated using the ΔΔCt method34. All experiments were performed with at least three independent biological replicates and three technical repeats. For the analysis of the expression of REST and AKAP13 isolated RNA was treated with DNase I using a DNA-Free™ kit (Ambion, Invitrogen) and subjected to cDNA synthesis as previously described35. Briefly, total RNA was reverse transcribed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems®) and the synthesized cDNAs were subjected to real time PCR using Luna Universal qPCR Master Mix (New England Biolabs, Ipswich, Massachusetts, United States) in the CFX Opus 96 Real-Time PCR System according to the manufacturer’s protocol. Specific primers used for this reaction were as follows: REST was amplified with 5′-GAGGAGGAGGGCTGTTTA-3′ (forward) and 5′-TCACAGCAGCTGCCATTT3′ (reverse), AKAP13 was amplified with 5′-TAGGAGAACGGAATCAGATAGTG-3′ (forward) and 5′-TCGCTCAGCACCAGTTTCT-3′ (reverse, while GAPDH was amplified with 5′-GGACCTGACCTGCCGTCTAG-3′ (forward) and 5′-CCACCACCCTGTTGCTGTAG-3′ (reverse) to control for equivalent amounts of cDNA per reaction. The relative level of REST and AKAP13 expression was determined using the ΔΔCt method34. All experiments were performed with at least three independent biological replicates and three technical repeats. Treatment procedure of transduced cells Following transduction with miR-219 lentiviral constructs or pGP, cells were plated for each experiment. After 24 h to allow for adhesion, both miR-219-transduced and pGP control cells were divided into four experimental groups: (1) untreated cells (Ctrl), (2) treatment with 50 µM TMZ (Sigma-Aldrich, SAD), (3) 4 Gy irradiation, and (4) combination of 50 µM TMZ treatment and 4 Gy irradiation (Fig. S5). These treatment groups were used throughout all subsequent experiments unless otherwise specified. X-ray radiation was delivered at 6 MeV using an Elekta Synergy linear accelerator. Cell viability assay The MTT assay was employed to evaluate the viability of GBM cell lines (LN229 and U87) following miR-219 transduction and treatments. miR-219-transduced cells and pGP control cells, were plated in 96-well plates at a density of 4,000 cells per well. After 24 h to allow for cell adhesion, cells were treated as described in the Treatment procedure section. At 48 h post-treatment, 10 µL of MTT solution (5 mg/mL; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added to each well, following the protocol described by Mosmann36 and Ohno and Abe37. After a 4 h incubation with MTT, 100 µL of 10% sodium dodecyl sulfate (SDS) was added to each well. Absorbance was measured at 570 nm using a Multiskan SkyHigh microplate spectrophotometer (Thermo Scientific™, Waltham, MA, USA). All experiments were performed using with at least three independent biological replicates, each containing three technical repeats. Colony formation assay miR-219-transduced and pGP control GBM cells (LN229 and U87) were seeded in triplicate in 6-well plates at a density of 800 cells per well. After 24 h cells were treated as described in the Treatment procedure section, and incubated for 10 days. Following incubation, the medium was removed and cells were rinsed with 1xPBS, fixed with 3.7% formaldehyde for 20 min, and stained with 0.5% crystal violet for 30 min at RT. Residual staining solution was removed by washing the cells several times with ddH2O. Plates were allowed to air-dry, and resulting colonies were imaged using digital camera. All experiments were performed with at least three independent biological replicates. Cell cycle analysis Cell cycle phase distribution was analyzed by flow cytometry38. After seeding 250,000 cells per well in 6-well plates and allowing a 24 h attachment period, cells were treated as previously described in the Treatment procedure section. After 48 h of incubation, cells were harvested by trypsinization, washed with 1xPBS, and fixed in cold 70% ethanol on ice. Following at least one-week storage at − 20 °C, cells were washed with PBS and incubated with RNase A in PBS for 30 min at 37 °C. Propidium iodide solution (PI) was then added and cells were incubated for an additional 10 min prior to analysis. For each cell sample, 10,000 events were acquired within the predefined gating parameters using a BD FACSCalibur™ flow cytometer (BD Biosciences, San Jose, CA, USA). The data obtained were analyzed using BD CellQuest™ Pro software (version 5.2.1; BD Biosciences, San Jose, CA, USA, https://www.bdbiosciences.com/en-eu). All experiments were performed with a minimum of three independent biological replicates. In vitro scratch assay miR-219-tranduced and pGP control LN229 cells were plated in 24-well plates, at a density of 120,000 cells per well, achieving for confluence 24 h post-seeding. A scratch was introduced into the cell monolayer using a pipette tip held perpendicular to the surface39. The cells were washed with 1xPBS, and then treated as described in the Treatment procedure section. Cell migration rate was photographed at two time points—0 h and 24 h after wounding using an inverted phase-contrast Olympus microscope (Olympus Corporation, Tokyo, Japan). Image analysis and quantification of the wound area in the confluent cell monolayer were conducted using browser version of ImageJ.js. All experiments were performed with at least three independent biological replicates and three technical repeats. Immunocytochemistry of 2D cells miR-219-trusduced and pGP control LN229 cells were plated directly onto coverslips at a density of 15,000 cells per well in 24-well plates. After 24 h, cells were treated as described in the Treatment procedure section. Following 48 h of incubation, cells were fixed in 3.7% formaldehyde for 20 min at RT and washed three times with 1 × PBS. Permeabilization and blocking were performed in a single step using a buffer containing 5% normal goat serum (NGS) (Merck KGaA, Darmstadt, Germany), 5% bovine serum albumin (BSA) (Sigma-Aldrich, MO, USA), and 0.1% Triton X-100 in 1xPBS for 45 min at RT. Following permeabilization and blocking, cells were washed three times with 1 × PBS, and incubated overnight at 4 °C with mouse anti-VIMENTIN primary antibody (SC-6260, Santa Cruz Biotechnology, 1:100 dilution) diluted in a blocking buffer containing 3% NGS, 3% BSA, and 0.1% Triton X-100 in 1xPBS. Following incubation with primary antibody, cells were washed three times in 1xPBS, and then incubated for 1 h at RT in the dark with Alexa Fluor 594‑conjugated goat anti‑mouse secondary antibody (Invitrogen™, 1:200 dilution) in buffer comprising 5% BSA and 0.1% Triton X‑100 in 1xPBS. Finally, cells were washed three times with 1xPBS and stained with diamino phenylindole (DAPI), diluted 1:2000 in 0.1% triton in PBS (Sigma-Aldrich, MO, USA) for 10 min at RT to visualize nuclei. The cells were observed and photographed with a fluorescence microscope (Axiovert 5, Zeiss, GMBH, Germany). 3D spheroid analysis To determine the effect of miR-219 on GBM spheroids, miR-219-transduced and pGP control GBM cells—LN229 (3000 cells per well) and U87 (2000 cells per well)—were seeded in a Nunclon™ Sphera™ 96-Well, Nunclon Sphera-treated, U-shaped-bottom microplates (Thermo Scientific™). After 48 h, cells formed 3D- spheroids in each well, as confirmed by light microscopy (Olympus Corporation, Tokyo, Japan), (data not shown). Spheroids were subsequently treated as described in the Treatment procedure section. To evaluate the effect of miR-219 on the spheroid size, spheroids were imaged before and 4 days post- treatment using an inverted phase-contrast Olympus microscope. Spheroids size was measured using the browser version of ImageJ.js. To analyze the effect of miR-219 on cell death, spheroids were stained with PI to detect dead cells (red signal). PI can’t penetrate live cell membranes and only binds to DNA in cells with compromised membranes. Following staining, spheroids were analyzed using a fluorescence microscope (Axiovert 5, Zeiss, GMBH, Germany). To determine the effect of miR-219 on VIMENTIN expression, Cleaved Caspase 3 and Cleaved PARP, spheroids were fixed in 3.7% formaldehyde after 4 days of post-treatment incubation. Permeabilization and blocking were performed for 2 h at RT using a solution containing 5% NGS, 5% BSA, and 0.1% Triton X-100 in 1xPBS. After this incubation, spheroids were incubated overnight at 4 °C with primary antibody (mouse monoclonal anti VIMENTIN -1:100 dilution, rabbit Cleaved Caspase 3 9661L Cell Signaling Technologies—1:100 dilution, Cleaved PARP (Asp214) (D64E10) XP® 5625S Cell Signaling Technologies—1:100 dilution) in blocking buffer containing 3% NGS, 5% BSA, and 0.2% Triton X-100 in 1xPBS. Spheroids were then incubated for 1 h at RT in the dark with secondary antibody (Alexa Fluor® 594-conjugated goat anti-mouse − 1:200 dilution, Alexa Fluor® 594-conjugated horse anti-rabbit-1:200 dilution) in 1xPBS containing 5% BSA and 0.1% Triton X-100. Afterwards, spheroids were stained with DAPI 1:2000 in 0,1% triton in PBS for 10 min at RT. The cells were observed and photographed with a fluorescence microscope (Axiovert 5, Zeiss, GMBH, Germany). Statistical analysis All experiments were performed in three repeats, and results are presented as means ± standard deviation (SD). Statistical analyses were conducted using GraphPad Prism 8.4.3. Differences between control and experimental groups were evaluated using unpaired Student’s t-test for single comparisons. For experiments involving multiple comparisons, multiple t-tests with false discovery rate (FDR) correction (1%) were applied, and adjusted p-values (q-values) were used to control for multiple comparisons. Statistical significance was defined as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001 for Student’s t-tests, and as *q ≤ 0.05, **q ≤ 0.01, ***q ≤ 0.001 for FDR-adjusted multiple t-tests. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Acknowledgements The authors would like to thank Marija Nedeljković for creating the Fig. S5. Author contributions Conceptualization, M.P., T.S., and D.S.N.; Methodology, M.P., L.B., S.L., I.M., and D.S.N.; Data analysis, M.P., L.B., S.L., I.M., and D.S.N.; Investigation, M.P., L.B., S.L., I.M., and D.S.N.; Resources, T.S. and M.N.; Data curation, M.P. and D.S.N.; Writing—original draft preparation, M.P. and D.S.N.; Writing—review and editing, M.P., L.B., S.L., I.M., T.S., M.N., and D.S.N.; Visualization, M.P. and D.S.N.; Supervision, T.S. and D.S.N. All authors have read and agreed to the published version of the manuscript. Funding This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (projects no. 451-03-33/2026-03/200042 and 451-03-33/2026-03/ 200043) and the University of Belgrade – Faculty of Medicine (Grant No 200110). Data availability No new datasets were generated during the current study. All gene expression data analyzed in this study are publicly available in the NCBI Gene Expression Omnibus (GEO) or TCGA repositories under the accession number listed in the Methods section. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Data Availability Statement No new datasets were generated during the current study. All gene expression data analyzed in this study are publicly available in the NCBI Gene Expression Omnibus (GEO) or TCGA repositories under the accession number listed in the Methods section.